THE RISE OF SEMAGLUTIDE: A GAME CHANGER FOR OBESITY TREATMENT

Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, copyright, is rapidly changing the landscape of weight loss. Prescribed by regulatory bodies for chronic weight management, Semaglutide works as a glucagon-like peptide-1 (GLP-1) receptor agonist.